Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Whats new CLL KC

    Launch of Chronic Lymphocytic Leukaemia (CLL)
    Knowledge Centre

    The new CLL Knowledge Centre contains useful resources for healthcare professionals
    treating this condition. There are three key areas: ‘Disease awareness’ (epidemiology,
    pathophysiology, diagnosis and treatment), ‘Events’ (upcoming meetings and congresses)
    and ‘Resources’ (links to useful sites and organisations).

  • ,AIKN CDI May Update

    Anti-Infectives Knowledge Network (AIKN) CDI Updates

    The Anti-Infectives Knowledge Network – Clostridium difficile infection (AIKN-CDI) has
    recently been updated with new content including presentation slides from EBMT and
    ECCMID 2015, a gut microflora animation unveiled at the Astellas stand during
    ECCMID 2015, recent articles added to the ‘CDI perspectives’ section and the
    opportunity to participate in a second round consensus questionnaire for the
    ​largest ever clinician consensus report.

    May 2015 MYC/15/0020/EUb

  • ,Whats New CSU

    Launch of Chronic Spontaneous Urticaria (CSU)
    Knowledge Centre

    A new Chronic Spontaneous Urticaria (CSU) Knowledge Centre has
    launched on epgonline.org to raise awareness and improve early diagnosis
    of the condition. Healthcare professionals will have free access to a
    disease overview, recent symposia highlights, a video channel and useful resources.

  • ,Whats new Psoriasis Knowledge centre

    Launch of Psoriasis Knowledge Centre

    A new Psoriasis Knowledge Centre has launched on epgonline.org
    to provide dermatologists, family medicine physicians and other healthcare
    professionals with free access to relevant information on psoriasis including
    pathophysiology, comorbidities, signs and symptoms, diagnosis and more.

  • ,What's New ECCMID IFI

    Anti-Infectives Knowledge Network (AIKN) IFI Updates

    The AIKN-IFI has been updated with four presentations from the Astellas-sponsored
    symposium at the 25th European Congress of Clinical Microbiology and Infectious
    Diseases (ECCMID) 2015
    . The congress took place on 25–28 April in Copenhagen,
    Denmark. Visit the congresses section of this resource to view and download the slides
    free of charge.

    May 2015 MYC/15/0040/EUb

Latest News

EU approves use of Perjeta (pertuzumab) plus Herceptin prior to surgery in early stage breast cancer- Roche


The EU has approved the use of Perjeta (pertuzumab), from Roche, in combination with Herceptin (trastuzumab) and chemotherapy for the neoadjuvant treatment (use before surgery) of adult patients with HER2-positive, locally advanced, inflammatory, or ...

FDA extends label of Abilify Maintena (aripiprazole) in schizophrenia- Otsuka


The FDA has expanded the label of Abilify Maintena (aripiprazole), from Otsuka, for extended-release injectable suspension to include a new injection site, the deltoid muscle of the arm. Healthcare providers will now have the option for either a ...

NT 0202 (extended release (ODT) amphetamine polistirex) refiled with FDA for ADHD-Neos Therapeutics


Neos Therapeutics has resubmitted a New Drug Application to the FDA for its amphetamine XR orally disintegrating tablet product candidate, NT 0202 (extended release (ODT) amphetamine polistirex), for the treatment of ADHD. The NT 0202 NDA ...

Positive Phase III results for plecanatide as treatment for chronic idiopathic constipation.- Synergy Pharmaceuticals


Synergy Pharmaceuticals Inc.has announced positive top-line results from the second of two pivotal phase III clinical trials evaluating the efficacy and safety of two different plecanatide treatment doses (3.0 mg and 6.0 mg), taken as a tablet ...

NICE recommendation for Daklinza + sofosbuvir to treat Hepatitis C- BMS


The National Institute for Health and Care Excellence (NICE) has recommended Daklinza (daclatasvir + sofosbuvir) from BMS to treat genotype 1 or genotype 4 Hepatitis C previously treated patients or those intolerant to treatment, without cirrhosis, ...

NICE recommends Viekira (ombitasvir + paritaprevir + ritonavir) + Exviera (dasabuvir) for treatment of genotype 1 Hepatitis C- AbbVie


The National Institute for Health and Care Excellence (NICE) recommends Viekira + Exviera ( ombitasvir + paritaprevir + ritonavir) with or without dasabuvir, from AbbVie, for treatment of genotype 1b Hepatitis C patients without cirrhosis or with ...

GI Dynamics discontinues ENDO trial of EndoBarrier therapy for obese patients with type 2 diabetes.


GI Dynamics, Inc. has announced its decision to discontinue its U.S. pivotal clinical trial of EndoBarrier Therapy (the ENDO Trial) for the treatment of obese patients who have uncontrolled type 2 diabetes. The decision follows discussions with the ...

Recent Updates


Clinical Guidelines

European Stroke Organisation (ESO) guidelines for the management of temperature in patients with acute ischemic stroke

Anaemia management in people with chronic kidney disease

Lower urinary tract symptoms: The management of lower urinary tract symptoms in men

Suspected cancer: recognition and referral

Medical Journals

Tiotropium and salmeterol in COPD patients at risk of exacerbations: a post hoc analysis from POET-COPD.

Functional Impairments Mediate Association Between Clinical Fracture Risk and Type 2 Diabetes Mellitus in Older Women.

Treating patients with metastatic castration-resistant prostate cancer: a comprehensive review of available therapies.

The Effect of Bisphosphonates on Bone Mineral Density in Metastatic Prostate Cancer Patients Who Are Treated with Anti-Androgen Drugs and Radiotherapy

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors